Coldstream Capital Management Inc. grew its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,112 shares of the company’s stock after purchasing an additional 439 shares during the quarter. Coldstream Capital Management Inc. owned approximately 0.08% of U.S. Physical Therapy worth $1,035,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Amalgamated Bank bought a new stake in U.S. Physical Therapy during the fourth quarter worth about $204,000. grace capital lifted its stake in U.S. Physical Therapy by 6.7% during the fourth quarter. grace capital now owns 17,788 shares of the company’s stock worth $1,821,000 after purchasing an additional 1,115 shares during the last quarter. Vestor Capital LLC bought a new stake in U.S. Physical Therapy during the fourth quarter worth about $51,000. BRYN MAWR TRUST Co lifted its stake in U.S. Physical Therapy by 1.1% during the fourth quarter. BRYN MAWR TRUST Co now owns 41,420 shares of the company’s stock worth $4,239,000 after purchasing an additional 435 shares during the last quarter. Finally, Thrivent Financial for Lutherans lifted its stake in shares of U.S. Physical Therapy by 2.2% in the 4th quarter. Thrivent Financial for Lutherans now owns 9,062 shares of the company’s stock valued at $928,000 after acquiring an additional 199 shares during the last quarter. Institutional investors own 99.58% of the company’s stock.
In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin purchased 500 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, March 29th. The shares were bought at an average price of $105.17 per share, for a total transaction of $52,585.00. Following the acquisition, the director now directly owns 2,500 shares in the company, valued at $262,925. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Lawrance W. Mcafee sold 3,150 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $106.43, for a total value of $335,254.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,754 shares of company stock worth $1,045,501. 2.50% of the stock is owned by company insiders.
U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Thursday, March 7th. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.08. U.S. Physical Therapy had a return on equity of 18.76% and a net margin of 5.07%. The company had revenue of $117.30 million for the quarter, compared to the consensus estimate of $116.70 million. The business’s quarterly revenue was up 7.4% on a year-over-year basis. As a group, equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.84 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, April 19th. Investors of record on Wednesday, March 20th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date was Tuesday, March 19th. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.23. U.S. Physical Therapy’s payout ratio is currently 40.75%.
A number of equities research analysts have recently weighed in on the company. ValuEngine lowered U.S. Physical Therapy from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, March 6th. William Blair assumed coverage on U.S. Physical Therapy in a research note on Thursday, March 7th. They issued an “outperform” rating and a $106.61 target price for the company. Zacks Investment Research lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Saturday, February 9th. Finally, TheStreet raised U.S. Physical Therapy from a “c+” rating to a “b” rating in a research note on Friday, March 8th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $111.90.
TRADEMARK VIOLATION NOTICE: This piece of content was posted by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.baseballdailydigest.com/news/2019/04/21/u-s-physical-therapy-inc-usph-position-increased-by-coldstream-capital-management-inc.html.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Story: 52-Week High/Low
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.